Literature DB >> 33875552

Select wisely: the ethical challenge of defining large core with perfusion in the early time window.

Ashutosh P Jadhav1, Werner Hacke2, Diederik W J Dippel3, Claus Ziegler Simonsen4, Vincent Costalat5, Jens Fiehler6, Goetz Thomalla7, Martin Bendszus8, Tommy Andersson9,10, Heinrich Paul Mattle11, Thabele M Leslie-Mazwi12, Maxim Mokin13, Albert J Yoo14, Osama O Zaidat15, Sunil A Sheth16, Tudor G Jovin17, David Liebeskind18.   

Abstract

Keywords:  CT perfusion; malignant; stroke; thrombectomy

Year:  2021        PMID: 33875552     DOI: 10.1136/neurintsurg-2021-017386

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


× No keyword cloud information.
  4 in total

1.  Characterizing reasons for stroke thrombectomy ineligibility among potential candidates transferred in a hub-and-spoke network.

Authors:  Robert W Regenhardt; Amine Awad; Andrew W Kraft; Joseph A Rosenthal; Adam A Dmytriw; Justin E Vranic; Anna K Bonkhoff; Martin Bretzner; Mark R Etherton; Joshua A Hirsch; James D Rabinov; Aneesh B Singhal; Natalia S Rost; Christopher J Stapleton; Thabele M Leslie-Mazwi; Aman B Patel
Journal:  Stroke Vasc Interv Neurol       Date:  2022-05-20

2.  Venous Outflow Profiles Are Linked to Clinical Outcomes in Ischemic Stroke Patients with Extensive Baseline Infarct.

Authors:  Laurens Winkelmeier; Gabriel Broocks; Helge Kniep; Vincent Geest; Jonathan Reinwald; Lukas Meyer; Noel van Horn; Adrien Guenego; Kamil Zeleňák; Gregory W Albers; Maarten Lansberg; Peter Sporns; Max Wintermark; Jens Fiehler; Jeremy J Heit; Tobias D Faizy
Journal:  J Stroke       Date:  2022-09-30       Impact factor: 8.632

3.  The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray-What Current Trials May Have Missed.

Authors:  Gabriel Broocks; Lukas Meyer; Rosalie McDonough; Matthias Bechstein; Uta Hanning; Jens Fiehler; Andre Kemmling
Journal:  Front Neurol       Date:  2022-01-14       Impact factor: 4.003

4.  Selection criteria for large core trials: rationale for the ANGEL-ASPECT study design.

Authors:  Zeguang Ren; Xiaochuan Huo; Gaoting Ma; Xu Tong; Jay Kumar; Elliot Pressman; Wenhuo Chen; Guangxiong Yuan; Alvin Yi-Chou Wang; Ming Wei; Jiangang Zhang; Guangxian Nan; Qiyi Zhu; Yajie Liu; Liyong Zhang; Weigen Song; Zhiming Zhou; Guoqing Wang; Tianxiao Li; Jun Luo; En Wang; Wentong Ling; Dongsheng Ju; Cunfeng Song; Shu-Dong Liu; Liqiang Gui; Tong Li; Yan Liu; Junfeng Zhao; Zaiyu Guo; Hongbo Zheng; Yaxuan Sun; Na Xu; Yong Jun Wang; Zhongrong Miao
Journal:  J Neurointerv Surg       Date:  2021-07-29       Impact factor: 5.836

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.